On May 12, the U.S. Food and Drug Administration (FDA) approved VEOZAHTM (Fezolinetant), 45 mg once daily for the treatment of moderate…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Innovator
-
-
2023 ApprovalsMay 2023Pharma ApprovalsU.S FDA
May 2023 Approval Update – Lexicon’s INPEFA™(Sotagliflozin) Notch FDA Approval for Treatment of Heart Failure
by adminby adminSummary:- INPEFA granted broad label across full range of left ventricular ejection fraction, including HFpEF and HFrEF, and for patients with or…
-
Ropeginterferon
FDA Approves Ropeginterferon Alfa-2b-njft (Besremi) Treatment for Rare Blood Disease Polycythemia Vera (PV).
by adminby adminSUMMARY: PharmaEssentia Corporation a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in…
-
Intellectual Property (IP)Patents
Med-X, Inc. Receives Patent on Nature-Cide Insecticidal Soil Formulation
by adminby adminKeypoints Med-X, Inc. announced that the Company received Patent No. 11,147,266 B2 for its Nature-Cide Insecticidal Soil formulation. Med-X’s goal is to…
-
AdamaAgro Science & ResearchAgrochemicalsCompaniesCortevaDowPatents
Adama is developing Dihydropyridine Class Fungicide – IP (Patent) Protected by Dow (Corteva)
by adminby adminLast week, May 28, 2020, Adama got a new PCT Patent application on a combination of “5-FLUORO-4-IMINO-3- METHYL-1-TOSYL-3,4-DIHYDROPYRIMIDIN-2-ONE” with other fungicides. Development…